5 high avidity diagnostic preparations in the nature of binding proteins for clinical or medical laboratory use in the medical, veterinary and environmental fields; high avidity binding proteins for use in the treatment or detection of viral, bacterial, fungal, helminth, mycoplasma, rickettsial, chlamydial or protozoan infections; high avidity binding proteins for use in the treatment or detection of diseases and conditions caused by natural immune hormones namely rheumatoid arthritis, Crohn's disease, osteoporosis, type 2 diabetes, diabetic retinopathy, congestive heart disease, lupus, scleroderma, psoriasis, aczema, ulcerative colitis, chronic fatigue syndrome, asthma, immediate and delayed hypersensitivity reactions, allergies, disorders of thrombosis and coagulation, atherosclerosis, alzheimers disease, multiple sclerosis and demyelination diseases, myasthenia gravis and diseases of neuromuscular junctions, diarrhea, fever, shock, obesity, transplant graft rejection; high avidity binding proteins for use in the treatment of detection of cancers, namely carcinomas, sarcomas, and leukemia; high avidity binding proteins for the use in blocking the activity of natural antibodies or lymphocytes that cause autoimmune diseases, namely type 1 diabetes, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, autoimmune hemolytic anemia and autoimmune thrombocytopenic purpura
Trademark: 75740293
